Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial

Nutting et al. (Fri,) studied this question.

www.synapsesocial.com/papers/69d725ba8a0e2c5879bef990 — DOI: https://doi.org/10.1016/s1470-2045(10)70290-4

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients· 2009 · 3,041 citations
2. Parotid gland function during and following radiotherapy of malignancies in the head and neck· 1992 · 245 citations
3. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC)· 1995 · 4,815 citations
4. New Guidelines to Evaluate the Response to Treatment in Solid Tumors· 2000 · 15,710 citations
5. Evidence-based review: Quality of life following head and neck intensity-modulated radiotherapy· 2010 · 54 citations